Clinical Trial Update: Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update covers a Phase 2 trial of zoledronic acid plus PET imaging in advanced non-small cell lung cancer, which was terminated and has results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Lung Cancer, Metastatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-02-04